DBVT
DBV Technologies
NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY
$21.00
+3.45% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
—
52W range
$8 – $26
Volume
0.2M
DBV Technologies (DBVT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,985.00%
ROE
-149.80%
ROA
-61.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | $130480.00 | $-6.07M | -86.60% | -5,753.37% | -4,651.29% |
| 2009 | $209057.00 | $-4.98M | -67.45% | -3,033.14% | -2,382.60% |
| 2010 | $236363.00 | $-6.36M | -35.54% | -3,456.97% | -2,689.51% |
| 2011 | $163373.00 | $-9.38M | -38.91% | -5,760.44% | -5,744.52% |
| 2012 | $230592.00 | $-17.02M | 52.42% | -7,664.19% | -7,382.74% |
| 2013 | $251318.00 | $-26.59M | 43.96% | -10,932.76% | -10,579.03% |
| 2014 | $256578.00 | $-29.07M | 35.54% | -11,622.20% | -11,327.94% |
| 2015 | $220847.00 | $-48.52M | 36.63% | -24,603.46% | -21,969.51% |
| 2016 | $7.93M | $-126.35M | 100.00% | -1,540.62% | -1,593.88% |
| 2017 | $11.52M | $-177.20M | 100.00% | -1,509.99% | -1,538.29% |
| 2018 | $12.81M | $-190.26M | 100.00% | -1,483.57% | -1,484.65% |
| 2019 | $14.71M | $-172.01M | 100.00% | -1,162.79% | -1,169.51% |
| 2020 | $11.28M | $-159.56M | 100.00% | -1,408.67% | -1,415.00% |
| 2021 | $5.71M | $-97.81M | -62.46% | -1,727.65% | -1,713.54% |
| 2022 | $4.80M | $-96.30M | -322.90% | -2,013.15% | -2,006.25% |
| 2023 | $15.73M | $-72.73M | 100.00% | -485.96% | -462.40% |
| 2024 | $2.57M | $-113.72M | -265.34% | -4,693.41% | -4,428.22% |
| 2025 | $0.00 | $-147.40M | — | — | — |